Please use this identifier to cite or link to this item:
https://ahro.austin.org.au/austinjspui/handle/1/34583
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Su, Elizabeth | - |
dc.contributor.author | Liew, David Fl | - |
dc.contributor.author | Donnelly, Jane | - |
dc.contributor.author | Elliott, Rohan A | - |
dc.date.accessioned | 2023-12-18T00:04:48Z | - |
dc.date.available | 2023-12-18T00:04:48Z | - |
dc.date.issued | 2023-08 | - |
dc.identifier.citation | Australian Prescriber 2023-08; 46(2) | en_US |
dc.identifier.uri | https://ahro.austin.org.au/austinjspui/handle/1/34583 | - |
dc.description.abstract | Medicines stewardship refers to coordinated strategies and interventions to optimise medicines use, usually within a specific therapeutic area. Medicines stewardship programs can reduce variations in practice and improve patient outcomes. Therapeutic domains for medicines stewardship are chosen to address frequently used drug classes associated with a high risk of adverse outcomes. Some examples include antimicrobial, opioid analgesic, anticoagulation and psychotropic stewardship. Common elements of successful stewardship programs include multidisciplinary leadership, stakeholder engagement, tailored communication strategies, behavioural changes, implementation science methodologies, and ongoing program monitoring, evaluation and reporting. Medicines stewardship is a continual quality improvement process that requires ongoing support and resources, as well as clinician and consumer engagement, to remain sustainable. It is critical for hospital-based medicines stewardship programs to consider impacts on care in the community when making and communicating changes to patient therapy. This ensures that stewardship efforts are sustained across transitions of care. | en_US |
dc.language.iso | eng | - |
dc.subject | anticoagulation stewardship | en_US |
dc.subject | antimicrobial stewardship | en_US |
dc.subject | medicines stewardship | en_US |
dc.subject | opioid analgesic stewardship | en_US |
dc.subject | psychotropic stewardship | en_US |
dc.subject | quality use of medicines | en_US |
dc.title | Medicines stewardship. | en_US |
dc.type | Journal Article | en_US |
dc.identifier.journaltitle | Australian Prescriber | en_US |
dc.identifier.affiliation | Austin Health | en_US |
dc.identifier.affiliation | Department of Medicine, University of Melbourne.;Council of Australian Therapeutic Advisory Groups.;Faculty of Pharmacy and Pharmaceutical Sciences, Monash University, Melbourne. | en_US |
dc.identifier.doi | 10.18773/austprescr.2023.010 | en_US |
dc.type.content | Text | en_US |
dc.identifier.orcid | 0000-0002-9893-5546 | en_US |
dc.identifier.orcid | 0000-0001-8451-8883 | en_US |
dc.identifier.orcid | 0000-0002-7750-9724 | en_US |
dc.identifier.pubmedid | 38053566 | - |
dc.description.volume | 46 | - |
dc.description.issue | 2 | - |
dc.description.startpage | 24 | - |
dc.description.endpage | 28 | - |
item.openairetype | Journal Article | - |
item.cerifentitytype | Publications | - |
item.grantfulltext | none | - |
item.fulltext | No Fulltext | - |
item.openairecristype | http://purl.org/coar/resource_type/c_18cf | - |
item.languageiso639-1 | en | - |
crisitem.author.dept | Pharmacy | - |
Appears in Collections: | Journal articles |
Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.